Company / Operating Cash Flow per Share
Processa Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.55
FY2022
5-year range
-$0.55 / -$0.08
FY2018-FY2022
Trend
-150.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.08 to $-0.55 over the past 6 years.
Based on SEC 10-K filings.
-0.55 in FY2022.
Declined from $-0.08 to $-0.55 over the past 6 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating cash flow per share decreased 150.4% year-over-year.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$0.55 | -150.4% |
| FY2021 | -$0.22 | -180.1% |
| FY2016 | -$0.08 | +67.8% |
| FY2015 | -$0.25 | +21.8% |
| FY2014 | -$0.31 | +69.4% |
| FY2013 | -$1.03 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026